116 related articles for article (PubMed ID: 37867114)
1. Sexual Dysfunction in Patients With Metastatic Breast Cancer.
Jahan N; Cathcart-Rake E; Vierkant RA; Larson N; Loprinzi C; O'Sullivan CC; Faubion S; Kuhle C; Vencill JA; Couch F; Olson JE; Ruddy KJ
Clin Breast Cancer; 2024 Jan; 24(1):72-78.e4. PubMed ID: 37867114
[TBL] [Abstract][Full Text] [Related]
2. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
Melisko ME; Goldman ME; Hwang J; De Luca A; Fang S; Esserman LJ; Chien AJ; Park JW; Rugo HS
JAMA Oncol; 2017 Mar; 3(3):313-319. PubMed ID: 27832260
[TBL] [Abstract][Full Text] [Related]
3. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer.
Juraskova I; Jarvis S; Mok K; Peate M; Meiser B; Cheah BC; Mireskandari S; Friedlander M
J Sex Med; 2013 Oct; 10(10):2549-58. PubMed ID: 23635341
[TBL] [Abstract][Full Text] [Related]
4. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
Kingsberg SA; Wysocki S; Magnus L; Krychman ML
J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
[TBL] [Abstract][Full Text] [Related]
5. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey.
Nappi RE; Particco M; Biglia N; Cagnacci A; Di Carlo C; Luisi S; Paoletti AM
Maturitas; 2016 Sep; 91():74-80. PubMed ID: 27451324
[TBL] [Abstract][Full Text] [Related]
6. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
[TBL] [Abstract][Full Text] [Related]
7. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
8. Female sexuality and vaginal health across the menopausal age.
Cagnacci A; Venier M; Xholli A; Paglietti C; Caruso S;
Menopause; 2020 Jan; 27(1):14-19. PubMed ID: 31738734
[TBL] [Abstract][Full Text] [Related]
9. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
Buchholz S; Mögele M; Lintermans A; Bellen G; Prasauskas V; Ortmann O; Grob P; Neven P; Donders G
Climacteric; 2015 Apr; 18(2):252-9. PubMed ID: 25427450
[TBL] [Abstract][Full Text] [Related]
10. Convergent-Divergent Validity and Correlates of the Day-to-Day Impact of Vaginal Aging Domain Scales in the MsFLASH Vaginal Health Trial.
Hunter MM; Guthrie KA; Larson JC; Reed SD; Mitchell CM; Diem SJ; LaCroix AZ; Huang AJ
J Sex Med; 2020 Jan; 17(1):117-125. PubMed ID: 31812686
[TBL] [Abstract][Full Text] [Related]
11. Prospective, multicenter, uncontrolled study on the effectiveness and safety of a hyaluronic acid water-based vaginal lubricant in alleviating vaginal dryness and dyspareunia.
Sánchez-Prieto M; Pingarrón C; Bergamaschi L; Bermúdez JC; Subiris González J; Sánchez Sánchez R; Poyo Torcal S; Gómez M; Ruiz Pérez ML; Castillo Martínez M; Peña Penedo ME; Sánchez-Borrego R
Gynecol Endocrinol; 2024 Mar; 40(1):2317268. PubMed ID: 38468593
[TBL] [Abstract][Full Text] [Related]
12. The impact of Sjӧgren's syndrome on the quality of sexual life of female patients in the UK: a controlled analysis.
Al-Ezzi M; Tappuni AR; Khan KS
Rheumatol Int; 2022 Aug; 42(8):1423-1429. PubMed ID: 33688999
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
[TBL] [Abstract][Full Text] [Related]
14. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial.
Hersant B; Werkoff G; Sawan D; Sidahmed-Mezi M; Bosc R; La Padula S; Kalsoum S; Ouidir N; Meningaud JP; Belkacemi Y
Ann Chir Plast Esthet; 2020 Jul; 65(4):e23-e31. PubMed ID: 32513482
[TBL] [Abstract][Full Text] [Related]
15. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
16. Sexual problems, communication patterns, and depressive symptoms in couples coping with metastatic breast cancer.
Milbury K; Badr H
Psychooncology; 2013 Apr; 22(4):814-22. PubMed ID: 22565300
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; BSc AB; Martel C; Vaillancourt M; Balser J; Moyneur É;
Menopause; 2018 Nov; 25(11):1339-1353. PubMed ID: 30358731
[TBL] [Abstract][Full Text] [Related]
18. Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program.
Carter J; Stabile C; Seidel B; Baser RE; Gunn AR; Chi S; Steed RF; Goldfarb S; Goldfrank DJ
Support Care Cancer; 2015 Aug; 23(8):2255-65. PubMed ID: 25567673
[TBL] [Abstract][Full Text] [Related]
19. Dyspareunia Related to GSM: Association of Total Vaginal Thickness via Transabdominal Ultrasound.
Balica AC; Cooper AM; McKevitt MK; Schertz K; Wald-Spielman D; Egan S; Bachmann GA
J Sex Med; 2019 Dec; 16(12):2038-2042. PubMed ID: 31542351
[TBL] [Abstract][Full Text] [Related]
20. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
